Determination of ABO blood type for prostate cancer patients

ABSTRACT: Purpose: This study uses a high-throughput glycan microarray to assign ABO blood type to patients from a clinical trial on PROSTVAC. The goal is to determine if blood type correlates with survival for patients treated with PROSTVAC Results: Blood types were assigned and type B and O patients were found to have longer survival than type A and AB patients Conclusion: Blood type may serve as a convenient method to identify patients likely to respond favorably to PROSTVAC therapy

ORGANISM(S): Homo sapiens Frangula alnus Gallus gallus

PROVIDER: GSE68404 | GEO | 2016/04/28

SECONDARY ACCESSION(S): PRJNA282664

REPOSITORIES: GEO